Intrinsic Value of S&P & Nasdaq Contact Us

Ingevity Corporation NGVT NYSE

NYSE • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
$282.54
+269%
Analyst Price Target
$76.67
+0.1%

Ingevity Corporation (NGVT) generated $331.2M in operating cash flow for fiscal year 2025. After capital expenditures of $57.7M, free cash flow was $273.5M.

Free cash flow margin was 23.4% of revenue. Cash conversion ratio was -1.98x, suggesting some earnings are non-cash.

The company returned $56.3M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (60/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (10/100) — Cash conversion ratio was -1.98x suggests some earnings are non-cash items

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
72/100
Price-to-Earnings & upside
→ Valuation
FUTURE
67/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
60/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
Ingevity Corporation Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $331.2M$331.2M$128.6M$205.1M$313.1M
Capital Expenditure $-57.7M$-57.7M$-77.6M$-109.8M$-142.5M
Free Cash Flow $273.5M$273.5M$51M$95.3M$170.6M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message